ACTRN12610000119099
Not yet recruiting
Phase 3
Study for the assessment of clinical non-inferiority and tolerability of Estrogenon drug – conjugated estrogens, coated tablets coated tablet manufactured by Sanval Comercio e Industria Ltda. in comparison to (PREMARIN) coated tablets manufactured by Wyeth Industria Farmaceutica Ltda. in women post menopause
Sanval Comercio e Industria Ltda0 sites66 target enrollmentFebruary 4, 2010
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Study with the purpose of check clinical non- inferiority and tolerance of conjugated estrogen coated tablet manufactured by different manufactures
- Sponsor
- Sanval Comercio e Industria Ltda
- Enrollment
- 66
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women in menopause with indications for estrogen replacement therapy.
Exclusion Criteria
- •Patients with contraindications for estrogen use.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Study for the assessment of clinical non-inferiority and tolerability of different conjugated estrogen vaginal cream ESTROGENON (Sanval Comercio e Industria Ltda) versus PREMARIN (Wyeth Industria Farmaceutica Ltda) in women post menopause.Study with the purpose of check clinical non-inferiority and tolerance of two vaginal cream based on the conjugated estrogen manufactured by different manufacturers.Women in post menopause with indications for estrogen replacement therapy.Reproductive Health and Childbirth - Menstruation and menopauseACTRN12610000103066Sanval Comercio e Industria Ltda.66
Completed
Phase 2
A clinical study to compare the effect of extract and crude form of Unani drug in the treatment of Gouty Arthritis.CTRI/2020/10/028663Ayurvedic and Unani Tibbia College Hospital40
Recruiting
Not Applicable
Clinical observational study for evaluation of the therapy outcome and the dependency of the outcome on parameters as reconstruction type and/or vitamin D level in OMS tumor patients in need of intra-oral tumor resection and reconstructioC01C02C03C04C05C06C44C40C41C07C08C09C10C11C12C13C14Malignant neoplasm of base of tongueMalignant neoplasm of other and unspecified parts of tongueMalignant neoplasm of gumMalignant neoplasm of floor of mouthMalignant neoplasm of palateMalignant neoplasm of other and unspecified parts of mouthOther malignant neoplasms of skinMalignant neoplasm of bone and articular cartilage of limbsMalignant neoplasm of bone and articular cartilage of other and unspecified sitesMalignant neoplasm of parotid glandMalignant neoplasm of other and unspecified major salivary glandsMalignant neoplasm of tonsilMalignant neoplasm of oropharynxMalignant neoplasm of nasopharynxMalignant neoplasm of piriform sinusMalignant neoplasm of hypopharynxMalignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynxDRKS00025841niversitätsklinikum derGoethe-Universität Frankfurt am MainKlinik für Mund-, Kiefer- und Plastische Gesichtschirurgie100
Active, not recruiting
Not Applicable
A non-inferiority study of the clinical effectiveness of anaesthesia obtained via application of Topical Anaesthetic Gel compared to infiltration of lidocaine for the treatment of lacerations in the Emergency DepartmentSmall to medium sized lacerations with no underlying nerve or other gross structural damage which would require further medical or surgical investigation.MedDRA version: 9.1Level: LLTClassification code 10023572Term: LacerationEUCTR2008-002467-13-GBorthern Health and Social Care Trust110
Not yet recruiting
Not Applicable
Evaluation of HF10 SCS therapy in FBSS patientsFBSS patients with predominant leg painPatiënten die voornamelijk beenpijn hebben na een gefaalde rugoperatieNL-OMON21128evro Corp.55